Cilostazol augments the inhibition of platelet aggregation in clopidogrel low-responders.
Lee
K
K
Kim
J-Y
JY
Yoo
B-S
BS
Yoon
J
J
Hong
M K
MK
Ahn
M-S
MS
Choe
H
H
Lee
S-H
SH
D001792:Blood Platelets / Q000187:drug effects*; D000077407:Cilostazol; D000077144:Clopidogrel; D004357:Drug Synergism; D054855:Drug-Eluting Stents; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010979:Platelet Function Tests; D011446:Prospective Studies; D058925:Receptors, Purinergic P2Y12 / Q000378:metabolism; D013777:Tetrazoles / Q000494:pharmacology*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D058925:Receptors, Purinergic P2Y12; D013777:Tetrazoles; D000077144:Clopidogrel; D000077407:Cilostazol; D013988:Ticlopidine